Filing Details

Accession Number:
0001209191-18-051357
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-18 12:37:11
Reporting Period:
2018-09-12
Accepted Time:
2018-09-18 12:37:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626878 Xbiotech Inc. XBIT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1211462 Thorpe W Mckenzie 8201 East Riverside Drive
Building 4, Suite 100
Austin TX 78744
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-09-12 41,675 $3.06 3,809,143 No 4 S Direct
Common Stock Disposition 2018-09-13 7,909 $3.10 3,801,234 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,500 Indirect Trust
Common Stock 100,000 Indirect Foundation
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.2, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.21, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.